CLONAL HAEMATOPOIESIS

CLONAL HAEMATOPOIESIS was reported 77 times

CLONAL HAEMATOPOIESIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Antimetabolite Immunosuppressant [EPC] 6 0.0003
1 CD33-directed Immunoconjugate [EPC] 1 0.0003
2 Interleukin-17A Antagonist [EPC] 10 0.0003
3 CD38-directed Cytolytic Antibody [EPC] 1 0.0002
4 Macrolide Antimicrobial [EPC] 7 0.0001
5 Epidermal Growth Factor Receptor Antagonist [EPC] 6 0.0001
6 Antirheumatic Agent [EPC] 11 0.0001
7 Aminosalicylate [EPC] 10 0.0001
8 Alkylating Drug [EPC] 19 0.0001
9 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 7 0.0001
10 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 8 0.0001
11 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 8 0.0001
12 Thrombopoietin Receptor Agonist [EPC] 1 0.0001
13 Platinum-based Drug [EPC] 16 0.0001
14 Thalidomide Analog [EPC] 28 0.0001
15 Human Immunoglobulin G [EPC] 1 0.0000
16 Nucleoside Metabolic Inhibitor [EPC] 12 0.0000
17 Proteasome Inhibitor [EPC] 5 0.0000
18 Topoisomerase Inhibitor [EPC] 3 0.0000
19 Androgen [EPC] 1 0.0000
20 Microtubule Inhibitor [EPC] 6 0.0000
21 Nucleoside Analog Antiviral [EPC] 3 0.0000
22 Vascular Endothelial Growth Factor Inhibitor [EPC] 6 0.0000
23 BCL-2 Inhibitor [EPC] 2 0.0000
24 Folate Analog Metabolic Inhibitor [EPC] 10 0.0000
25 Corticosteroid [EPC] 28 0.0000
26 CD20-directed Cytolytic Antibody [EPC] 6 0.0000
27 Erythropoiesis-stimulating Agent [EPC] 1 0.0000
28 Retinoid [EPC] 4 0.0000
29 Tumor Necrosis Factor Blocker [EPC] 13 0.0000
30 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
31 Leukocyte Growth Factor [EPC] 1 0.0000
32 Azole Antifungal [EPC] 1 0.0000
33 Mood Stabilizer [EPC] 1 0.0000
34 Anti-epileptic Agent [EPC] 1 0.0000
35 Platelet Aggregation Inhibitor [EPC] 1 0.0000
36 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000